News Archive

The American Society of Breast Surgeons (ASBrS) and Society of Breast Imaging (SBI) are developing evidence-informed, clinical consensus guidelines for the management of four benign breast disease entities. ASBrS and SBI are publishing these guidelines to provide trusted, actionable decision support to clinicians who manage the treatment of benign breast disease. The guidelines presented here for public comment represent Atypical Lobular Hyperplasia (ALH) and Lobular carcinoma in situ (LCIS) and Atypical Ductal Hyperplasia (ADH) and Flat epithelial atypia (FEA).

Primary results of the INSEMA (Intergroup-Sentinel-Mamma) trial were presented at the 2024 San Antonio Breast Cancer Symposium and simultaneously published online in the NEJM on December 12, 2024. The authors concluded that axillary sentinel lymph node surgery can be safely omitted in patients with clinically node-negative early breast cancer undergoing upfront breast-conserving surgery and whole breast radiation (breast-conserving therapy).

The Society’s Call for Volunteers is now open! We are excited to offer opportunities on 18 committees, each with a unique and specialized focus.

ASBrS President Dr. Judy C. Boughey expresses warm holiday wishes to our community of breast surgeons.